A Pečauer’s Reviews > Bottle of Lies: The Inside Story of the Generic Drug Boom > Status Update
A Pečauer
is 23% done
Chapter 7: The reluctance of pharmaceutical companies to prematurely yield their legitimate patent licenses "even brought accusations of genocide."
Note that it costs zero dollars to make an a vague accusation of genocide, regardless of its adherence to the definition. That low financial barrier predictably means everything we don't like is genocide.
It's not an especially notable observation.
— Aug 31, 2025 07:46PM
Note that it costs zero dollars to make an a vague accusation of genocide, regardless of its adherence to the definition. That low financial barrier predictably means everything we don't like is genocide.
It's not an especially notable observation.
Like flag
A’s Previous Updates
A Pečauer
is 49% done
Baker's adherence to lawful regulatory requirements affected the sweet bottom line. "Consequently, some in [the FDA] began to target a different problem--Peter Baker himself."
They have hated those who are presenting their cases in court, detesting the one who speaks truthfully. (Amos 5:10) (lol)
— Sep 01, 2025 03:33PM
They have hated those who are presenting their cases in court, detesting the one who speaks truthfully. (Amos 5:10) (lol)
A Pečauer
is 49% done
Chapter 16: I’m glad that the only pharmaceutical companies in my investment portfolio are Japanese. I feel assured that any possible fraud committed on their part is largely limited to the financial sort, and is bound to be much less sloppy.
— Aug 31, 2025 10:57PM
A Pečauer
is 28% done
"It is not in Indian culture to record our data while we conduct experiments."
A quote from Rambaxy Laboratories' Head of Analytical Research.
One of the funnier quotes I’ve read this year.
— Aug 31, 2025 08:25PM
A quote from Rambaxy Laboratories' Head of Analytical Research.
One of the funnier quotes I’ve read this year.
